Health Catalyst (HCAT)
NASDAQ:HCAT
Earnings Data
Report Date
May 12, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.02Last Year’s EPS
0.01Same Quarter Last Year
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call conveyed constructive operational progress — margin expansion, strong adjusted EBITDA growth (59% YoY), 7% technology revenue growth, improved cost discipline, and strategic leadership actions to simplify the commercial story. However, these positives are tempered by material near-term risks: a large $110.2M GAAP impairment, quarterly revenue decline, professional services weakness, and significant DOS-to-Ignite migration headwinds (~$12.5M confirmed churn and ~$52.0M at risk, incl. $35.0M data infrastructure). Management is investing to address migrations and future AI-enabled opportunities but withheld full-year guidance pending strategic review. Overall, the call reflects operational improvement underpinned by meaningful execution risks and financial uncertainty.Company Guidance
Full-Year Revenue and Technology Growth
Total revenue for FY2025 was $311.1M, representing 1% year-over-year growth. Technology revenue increased 7% year-over-year to $208.3M, indicating strength in the software/technology business despite overall modest topline growth.
Adjusted EBITDA and Margin Expansion
Adjusted EBITDA for FY2025 was $41.4M, a 59% increase year-over-year. Q4 adjusted EBITDA was $13.8M versus $7.9M in the prior-year quarter. Adjusted gross margin improved (Q4 adjusted gross margin 53.5% vs 46.6% prior-year; FY adjusted gross margin 51.1%) reflecting benefit from restructuring and cost discipline.
Improved Operating Efficiency
Adjusted operating expenses declined to $117.7M for FY2025 (38% of revenue) from $123.4M (40% of revenue) in FY2024. Q4 adjusted operating expenses were $26.2M (35% of revenue) vs $29.2M (37%) prior-year. Sequentially, adjusted operating expenses declined by $2.0M versus Q3 due to restructuring and workforce optimization.
Client Acquisition and Retention Indicators
Closed FY2025 with 32 net new logos (above target of 30, below the original expectation of 40). TAC + TEMS dollar-based retention finished the year at 90%. New logos had average ARR plus non-recurring revenue near the midpoint of the $300K–$700K range.
Balance Sheet Liquidity
Year-end cash, cash equivalents, and short-term investments were approximately $96.0M, providing liquidity while term loan debt outstanding was $161.0M.
Strategic and Leadership Actions
New CEO (internal promotion) initiated organizational review, tightened commercial focus, appointed GMs for interoperability and cybersecurity, searched for COO and CMO, and prioritized bookings, retention, AI R&D investments and simplified reporting — indicating focused strategic intent to improve execution and long-term value.
HCAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HCAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 12, 2026 | $1.79 | $1.32 | -26.26% |
Nov 10, 2025 | $2.85 | $2.69 | -5.61% |
Aug 07, 2025 | $3.69 | $2.83 | -23.31% |
May 07, 2025 | $3.97 | $4.18 | +5.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Health Catalyst (HCAT) report earnings?
Health Catalyst (HCAT) is schdueled to report earning on May 12, 2026, After Close (Confirmed).
What is Health Catalyst (HCAT) earnings time?
Health Catalyst (HCAT) earnings time is at May 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HCAT EPS forecast?
HCAT EPS forecast for the fiscal quarter 2026 (Q1) is 0.02.
